ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,457.36
0.47%
Dow Jones
38,699.94
0.29%
US Dollar vs MXN
18.51027
0.25%
Brent Oil
83.205
1.32%
Bitcoin
65,820.00
-1.23%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nexvet Biopharma Plc - Ordinary Shares (NVET)

  7. Nexvet Biopharma Plc - Ordinary Shares (NVET) Noticias

NVET

NEXVET BIOPHARMA PLC (NVET)

Nexvet Biopharma Plc - Ordinary Shares
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NVET
FechaHoraFuenteTítuloSímboloCompañía
13/02/201815:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
10/08/201715:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
08/08/201716:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
02/08/201715:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201708:07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201708:02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201707:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201707:45Edgar (US Regulatory)(25-NSE)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
31/07/201707:00Business WireZoetis Completes Acquisition of Nexvet BiopharmaNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
28/07/201707:51GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17(d) AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
10/07/201708:56GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17(c) AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
05/07/201709:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
05/07/201704:30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 2.10 AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
03/07/201704:30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Supplement AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
19/06/201715:07PR Newswire (US)WeissLaw LLP Files Class Action Lawsuit Against Nexvet Biopharma PLCNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
16/06/201704:30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 15 AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
13/06/201712:07Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
06/06/201723:11GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17(b) AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
02/06/201716:20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
02/06/201707:30GlobeNewswire Inc.Nexvet Biopharma plc ("Nexvet") Rule 17 AnnouncementNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
01/06/201715:14PR Newswire (US)Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Nexvet Biopharma Public Limited Company - NVETNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/05/201716:14Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/05/201705:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/05/201704:30GlobeNewswire Inc.Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
13/04/201720:02Business WireZoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion AnimalsNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
22/02/201704:30GlobeNewswire Inc.Nexvet to Present at the Cowen and Company 37th Annual Health Care ConferenceNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
10/02/201704:30GlobeNewswire Inc.Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/01/201716:57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
11/01/201716:00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
12/12/201604:30GlobeNewswire Inc.Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in CatsNASDAQ:NVETNexvet Biopharma Plc - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:NVET

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
DIS
Walt Disney
USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
CCOM
OILBRENT
Brent Oil
USOTC
ADDYY
Adidas (QX)
FX
USDMXN
US Dollar vs MXN
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados